Aerovate Therapeutics, Inc. (AVTE) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 356 transactions totaling $90.3M, demonstrating a bullish sentiment with $54.8M in net insider flow. The most recent transaction on Aug 1, 2024 involved a transaction of 1,507 shares valued at $2.6K.
No significant insider buying has been recorded for AVTE in the recent period.
No significant insider selling has been recorded for AVTE in the recent period.
Based on recent SEC filings, insider sentiment for AVTE is bullish with an Insider Alignment Score of 80/100 and a net flow of $54.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Aerovate Therapeutics, Inc. (AVTE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading AVTE stock, having executed 356 transactions in the past 90 days. The most active insider is Rajeev M. Shah (Executive), who has made 5 transactions totaling $40.5M.
Get notified when executives and directors at AVTE file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 1, 2024 | T. Dake Benjamin | Executive | Option Exercise | 1,507 | $1.74 | $2.6K | |
| Jul 31, 2024 | T. Dake Benjamin | Executive | Option Exercise | 11,454 | $1.74 | $19.9K | |
| Jun 17, 2024 | M. Shah Rajeev | Executive | Purchase | 928,110 | $1.67 | $1.5M | Large |
| Jun 14, 2024 | Verwijs Marinus | Executive | Option Exercise | 10,600 | $14.59 | $154.7K | 10b5-1 |
| Jun 14, 2024 | Verwijs Marinus | Executive | Sale | 10,600 | $25.00 | $265.0K | 10b5-1 |
| Jun 14, 2024 | A. Eldridge George | Executive | Option Exercise | 15,000 | $2.14 | $32.1K | 10b5-1 |
| Jun 14, 2024 | A. Eldridge George | Executive | Sale | 15,000 | $25.03 | $375.4K | 10b5-1 |
| Jun 13, 2024 | Gillies Hunter | Executive | Option Exercise | 6,000 | $2.14 | $12.8K | 10b5-1 |
| Jun 13, 2024 | Gillies Hunter | Executive | Sale | 6,000 | $24.50 | $147.0K | 10b5-1 |
| May 17, 2024 | Gillies Hunter | Executive | Option Exercise | 4,000 | $2.14 | $8.6K | 10b5-1 |
| May 17, 2024 | Gillies Hunter | Executive | Sale | 3,914 | $21.07 | $82.5K | 10b5-1 |
| May 17, 2024 | Gillies Hunter | Executive | Sale | 86 | $21.86 | $1.9K | 10b5-1 |
| May 16, 2024 | P. Noyes Timothy | Executive | Sale | 8,707 | $21.52 | $187.4K | 10b5-1 |
| May 16, 2024 | P. Noyes Timothy | Executive | Sale | 1,293 | $21.92 | $28.3K | 10b5-1 |
| May 16, 2024 | P. Noyes Timothy | Executive | Option Exercise | 10,000 | $2.14 | $21.4K | 10b5-1 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 7 | $72.5M | 78.4% |
Sale(S) | 194 | $17.7M | 19.2% |
Exercise(M) | 145 | $2.2M | 2.4% |
Other(J) | 2 | $0 | 0.0% |
Conversion(C) | 8 | $0 | 0.0% |
Insiders at Aerovate Therapeutics, Inc. are accumulating shares at an accelerated pace. With 12 insiders making 356 transactions totaling $72.5M in purchases versus $17.7M in sales, the net buying activity of $54.8M signals strong executive confidence. Rajeev M. Shah (Executive) leads the buying activity with $40.5M in transactions across all time.